Melior Discovery is a provider of in vivo pharmacology services. It evaluates candidate therapeutics in animal models of human diseases. The company develops a platform that validates animal models in a range of therapeutic areas, including inflammation, immunology, diabetes, dermatology, cardiovascular, gastrointestinal, psychiatric, neurological and other disorders.